Hospital Clinic of Barcelona
Hospital Clinic of Barcelona
Barcelona, Spain4 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| AutoInflammatory Disease Alliance Registry (AIDA) | Behcet disease, Castleman disease, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hemic and Lymphatic Diseases, Marshall syndrome, PFAPA syndrome, Schnitzler syndrome, Skin and Connective Tissue Diseases, Spondylarthritis, Stomatognathic Diseases, VEXAS syndrome, anterior uveitis, arthritic joint disease, arthropathy, autoimmune disease, bone disorder, cardiovascular disorder, connective tissue disorder, eye disorder, hereditary disease, hereditary periodic fever syndrome, hereditary skin disorder, immune system disorder, immunoproliferative disorder, juvenile idiopathic arthritis, lymphatic system disorder, lymphoproliferative syndrome, monoclonal gammopathy, monoclonal gammopathy of uncertain significance, mouth disorder, musculoskeletal system disorder, panuveitis, rheumatic disorder, scleral disorder, scleritis, skin disorder, skin vascular disease, spondylitis, systemic-onset juvenile idiopathic arthritis, uveal disorder, uveitis, vascular disorder, vasculitis, vertebral column disorder | Recruiting | Not stated | 2025-07-10 | NCT05200715 | |
| Assessment of Transcatheter Edge-to-Edge Repair in Atrial Functional Mitral Regurgitation (ATRIAL-MR) | cardiovascular disorder, heart disorder, heart valve disorder, mitral valve insufficiency | Recruiting | Not stated | 2025-04-06 | NCT06911099 | |
| A Prospective Non-interventional Observational Study to Observe Long-term Treatment and Outcomes in Pulmonary Arterial Hypertension (PAH) Patients | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Enrolling by invitation | Not stated | 2024-08-07 | NCT06445673 | |
| Initial Triple Therapy Including Parenteral Treprostinil vs Initial Double Oral Therapy in PAH Group I Patients | lung disorder, pulmonary arterial hypertension, pulmonary hypertension, respiratory system disorder | Recruiting | Phase 4 | 2024-03-19 | NCT06317805 |